Your browser doesn't support javascript.
loading
With Current Safety and Efficacy Data, Should Statins Be Made Available as Nonprescription Over-the-Counter Drugs?
Mehta, Anurag; Dixon, Dave L; Saeed, Anum; Kelly, Michael S; Gulati, Martha; Shapiro, Michael D; Sperling, Laurence S; Virani, Salim S.
  • Mehta A; VCU Health Pauley Heart Center and Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
  • Dixon DL; VCU Health Pauley Heart Center and Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, VA, USA.
  • Saeed A; Heart and Vascular Institute, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  • Kelly MS; Thomas Jefferson College of Pharmacy, Thomas Jefferson University, Philadelphia, PA, USA.
  • Gulati M; Cedars-Sinai Medical Center, Barbra Streisand Women's Heart Center, Smidt Heart Institute, Los Angeles, CA, USA.
  • Shapiro MD; Center for Prevention of Cardiovascular Disease, Section On Cardiovascular Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
  • Sperling LS; Emory Clinical Cardiovascular Research Institute, Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • Virani SS; Department of Medicine, The Aga Khan University, Karachi, Pakistan. salim.virani@aku.edu.
Curr Cardiol Rep ; 25(5): 423-430, 2023 05.
Article en En | MEDLINE | ID: mdl-36971960
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Aterosclerosis Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Aterosclerosis Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article